Adam Lavertu

1.0k total citations
15 papers, 510 citations indexed

About

Adam Lavertu is a scholar working on Molecular Biology, Toxicology and Genetics. According to data from OpenAlex, Adam Lavertu has authored 15 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Toxicology and 4 papers in Genetics. Recurrent topics in Adam Lavertu's work include Pharmacovigilance and Adverse Drug Reactions (3 papers), Genomics and Rare Diseases (3 papers) and Genetic Associations and Epidemiology (3 papers). Adam Lavertu is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (3 papers), Genomics and Rare Diseases (3 papers) and Genetic Associations and Epidemiology (3 papers). Adam Lavertu collaborates with scholars based in United States, Germany and Netherlands. Adam Lavertu's co-authors include Russ B. Altman, Gregory McInnes, Michelle Whirl‐Carrillo, Teri E. Klein, Manuel A. Rivas, Katrin Sangkuhl, Yosuke Tanigawa, Kathleen M. Giacomini, Bianca Vora and Stefano Rensi and has published in prestigious journals such as Nature Communications, Bioinformatics and PLoS ONE.

In The Last Decade

Adam Lavertu

15 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Lavertu United States	11	197	185	157	52	51	15	510
Christina Mitropoulou Greece	15	145 0.7×	208 1.1×	237 1.5×	8 0.2×	86 1.7×	42	562
Gregory McInnes United States	10	150 0.8×	193 1.0×	159 1.0×	5 0.1×	54 1.1×	12	414
Padmaja Mummaneni United States	13	439 2.2×	170 0.9×	152 1.0×	8 0.2×	87 1.7×	15	817
Marisa Papaluca‐Amati Netherlands	10	53 0.3×	40 0.2×	106 0.7×	21 0.4×	62 1.2×	11	395
Jennifer Gjerde Norway	18	230 1.2×	483 2.6×	295 1.9×	11 0.2×	32 0.6×	29	938
M. van Vliet Netherlands	15	285 1.4×	159 0.9×	245 1.6×	8 0.2×	46 0.9×	35	785
Cornelia von Hagens Germany	10	143 0.7×	33 0.2×	39 0.2×	23 0.4×	91 1.8×	19	520
Giovanni Bocci United States	11	400 2.0×	198 1.1×	57 0.4×	7 0.1×	39 0.8×	14	785
Roman Tremmel Germany	13	186 0.9×	91 0.5×	197 1.3×	4 0.1×	52 1.0×	33	481
David Sexton United States	11	566 2.9×	143 0.8×	145 0.9×	6 0.1×	31 0.6×	15	917

Countries citing papers authored by Adam Lavertu

Since Specialization

Citations

This map shows the geographic impact of Adam Lavertu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Lavertu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Lavertu more than expected).

Fields of papers citing papers by Adam Lavertu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Lavertu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Lavertu. The network helps show where Adam Lavertu may publish in the future.

Co-authorship network of co-authors of Adam Lavertu

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Lavertu. A scholar is included among the top collaborators of Adam Lavertu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Lavertu. Adam Lavertu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lavertu, Adam, Tymor Hamamsy, Keith Humphreys, et al.. (2025). Monitoring the opioid epidemic via social media discussions. npj Digital Medicine. 8(1). 284–284. 3 indexed citations

Chen, Binbin, Amit Kaushal, Adam Lavertu, et al.. (2021). Repurposing biomedical informaticians for COVID-19. Journal of Biomedical Informatics. 115. 103673–103673. 1 indexed citations

Lavertu, Adam, Bianca Vora, Kathleen M. Giacomini, Russ B. Altman, & Stefano Rensi. (2021). A New Era in Pharmacovigilance: Toward Real‐World Data and Digital Monitoring. Clinical Pharmacology & Therapeutics. 109(5). 1197–1202. 66 indexed citations

Lavertu, Adam, Tymor Hamamsy, & Russ B. Altman. (2021). Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis. Journal of Medical Internet Research. 23(10). e27714–e27714. 8 indexed citations

DeBoever, Christopher, Yosuke Tanigawa, Matthew Aguirre, et al.. (2020). Assessing Digital Phenotyping to Enhance Genetic Studies of Human Diseases. The American Journal of Human Genetics. 106(5). 611–622. 28 indexed citations

McInnes, Gregory, Adam Lavertu, Katrin Sangkuhl, et al.. (2020). Pharmacogenetics at Scale: An Analysis of the UK Biobank. Clinical Pharmacology & Therapeutics. 109(6). 1528–1537. 97 indexed citations

Lavertu, Adam, et al.. (2019). Genome-Wide Analysis of Cell Cycle-Regulating Genes in the Symbiotic Dinoflagellate Breviolum minutum. G3 Genes Genomes Genetics. 9(11). 3843–3853. 4 indexed citations

Morgens, David W., N. Weir, Amy Li, et al.. (2019). Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteins. eLife. 8. 16 indexed citations

Lavertu, Adam & Russ B. Altman. (2019). RedMed: Extending drug lexicons for social media applications. Journal of Biomedical Informatics. 99. 103307–103307. 13 indexed citations

10.

Sangkuhl, Katrin, Michelle Whirl‐Carrillo, Ryan Whaley, et al.. (2019). Pharmacogenomics Clinical Annotation Tool (Pharm CAT ). Clinical Pharmacology & Therapeutics. 107(1). 203–210. 68 indexed citations

11.

Gijsen, Violette, Michele H. Maddux, Adam Lavertu, et al.. (2019). #Science: The Potential and the Challenges of Utilizing Social Media and Other Electronic Communication Platforms in Health Care. Clinical and Translational Science. 13(1). 26–30. 11 indexed citations

12.

DeBoever, Christopher, Yosuke Tanigawa, Maléne E. Lindholm, et al.. (2018). Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study. Nature Communications. 9(1). 1612–1612. 61 indexed citations

13.

McInnes, Gregory, Yosuke Tanigawa, Adam Lavertu, et al.. (2018). Global Biobank Engine: enabling genotype-phenotype browsing for biobank summary statistics. Bioinformatics. 35(14). 2495–2497. 44 indexed citations

14.

Lavertu, Adam, Gregory McInnes, Roxana Daneshjou, et al.. (2018). Pharmacogenomics and big genomic data: from lab to clinic and back again. Human Molecular Genetics. 27(R1). R72–R78. 19 indexed citations

15.

Stone, Oliver A., Samuel Lessard, Adam Lavertu, et al.. (2017). Frameshift indels introduced by genome editing can lead to in-frame exon skipping. PLoS ONE. 12(6). e0178700–e0178700. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact